Brief: vTv Therapeutics Says Company’S Cash Position As Of December 31, 2021, Was $13.4 Million
Brief: VTV Therapeutics Announces CEO Transition
Brief: vTv Therapeutics Inc Says Deepa Prasad Notified Co's Board Of Her Decision To Resign As CEO
vTv Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: vTv Therapeutics Inc - Received A Letter From Nasdaq Notifying Company That It Is Not In Compliance With Requirement Of Nasdaq Rule
vTv Therapeutics rises on job cut plan to focus on adjunct therapy for diabetes
Brief: vTv Therapeutics Inc Says co's Dec. 6 Strategic Decision Includes Reduction In Workforce Affecting About 65% Of Employees
Brief: vTv Therapeutics Announces Restructuring To Prioritize Its Lead Program And Focus Operations
Brief: vTv Therapeutics Inc Says Rudy Howard Announced His Resignation As Chief Financial Officer
vTv Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: vTv Therapeutics Reports Q3 Loss Per Share Of $0.02
vTv Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Vtv Therapeutics Announces Deepa Prasad As New President And CEO
Refinitiv Newscasts - Vietnam flooding and landslides kill three
Brief: Vtv Therapeutics Announces Positive Results From Mechanistic Study
U.S. STOCKS ON THE MOVE-Aehr, Costco, Onconova, restaurant stocks
U.S. STOCKS ON THE MOVE-Capricor Therapeutics, Nike, Meredith Corp
U.S. STOCKS ON THE MOVE-Alibaba Group, vTv Therapeutics, crypto stocks
vTv Therapeutics rises on positive psoriasis drug trial results